Description 5-Amino-1MQ Overview (5-amino-1-methylquinolinium), a structural analogue of methylquinolinium, is a small-molecule inhibitor of the cytosolic enzyme nicotinamide N-methyltransferase (NNMT)
Participants received weekly subcutaneous injections of retatrutide at 0.5 mg, 4.0 mg, 8.0 mg, or 12 mg, placebo, or 1.5 mg dulaglutide over 36 weeks
Safety is also important
In the meantime, the new data could still provide guidance to people with diabetes and their doctors, Patell said
The American Heart Association's Heart Disease and Stroke Statistics report has documented significant racial disparities in comorbidity management outcomes and healthcare delivery [116]
It is well-tolerated with essentially no side effects, making it an attractive option for patients who prefer non-pharmacological approaches